Exact Sciences (EXAS) Liabilities and Shareholders Equity (2010 - 2025)

Exact Sciences (EXAS) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $5.9 billion in Q4 2025.

• Liabilities and Shareholders Equity for Q4 2025 came in at $5.9 billion, down 1.14% year-over-year; the trailing twelve-month figure through Dec 2025 was $23.3 billion (down 9.55% YoY), and the FY2025 annual result was $5.9 billion, down 1.14% from the prior year.
• Liabilities and Shareholders Equity fell to $5.9 billion in Q4 2025 per EXAS's latest filing, from $5.9 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $6.7 billion in Q3 2024 and troughed at $5.7 billion in Q1 2025.
• A 5-year average of $6.3 billion and a median of $6.4 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2021 and 2025: Liabilities and Shareholders Equity jumped 52.82% in 2021, then dropped 13.13% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $6.7 billion in 2021, then dropped by 6.85% to $6.2 billion in 2022, then grew by 3.93% to $6.5 billion in 2023, then decreased by 8.39% to $5.9 billion in 2024, then retreated by 1.14% to $5.9 billion in 2025.
• Business Quant data shows EXAS's Liabilities and Shareholders Equity at $5.9 billion in Q4 2025, $5.9 billion in Q3 2025, and $5.8 billion in Q2 2025.